Ashvattha Therapeutics

Redwood City, CA · Founded 2015 · Privately Held (backing)

Developer of hydroxyl dendrimer therapeutics designed to meet the unmet medical needs in oncology, ophthalmology and inflammatory diseases. Ashvattha Therapeutics is based in Redwood City, CA and was founded in 2015. It was valued at $310 million at its later-stage round in Jan 2025, the last priced event on record. It has raised $217 million across 4 recorded rounds; the latest was a $60.2 million later-stage round in Apr 2021.

PMV mark · valuation
$310.0M
Oct 2026
Priced at
its later-stage round
Jan 2025
Total raised
$217.2M
Last round
Later Stage VC
Apr 2021
How much has Ashvattha Therapeutics raised?
$217.2Macross 4 recorded rounds · Feb 2016 – Apr 2021

Most recently, Ashvattha Therapeutics raised $60.2M in its Later Stage VC (Apr 2021).

Free account
More of Ashvattha Therapeutics with a free account
  • ·The complete investor list: 37 names
  • ·Watch Ashvattha Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Ashvattha Therapeutics round by round

4 rounds
Apr 2021Later Stage VC$60.2MSEC filing▮
107 investors participated
May 2019Seed Round$250KSEC filing▮
1 investors participated
May 2018Seed Round$400KSEC filing▮
1 investors participated
Feb 2016Seed Round$300KSEC filing▮
4 investors participated

How much has Ashvattha Therapeutics raised?

Ashvattha Therapeutics has raised $217 million in total; 4 of its rounds are on record, from 2016 on. The largest on record was a $60.2 million later-stage round in Apr 2021.

Ashvattha Therapeutics has filed 7 Form Ds with the SEC since 2016, most recently in Dec 2022 ($60.2 million sold to 107 investors).

Ashvattha Therapeutics investors

37 investors are on record for Ashvattha Therapeutics, including Evolution VC Partners, Tribe Capital, TEDCO and Sand Hill Angels. By type, the record holds 9 venture capital firms, 1 family office and 1 hedge fund. The later-stage round in Apr 2021 drew 107 investors.

For fundraisers
Raising for a company like Ashvattha Therapeutics?

37 investors have backed Ashvattha Therapeutics.

See all 37 investors →

Frequently asked about Ashvattha Therapeutics

How much has Ashvattha Therapeutics raised?
Ashvattha Therapeutics has raised $217.2M in total across 4 recorded funding rounds.
When was Ashvattha Therapeutics's last funding round?
Ashvattha Therapeutics's most recent recorded round was Later Stage VC in Apr 2021, raising $60.2M.